CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 55  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0869
LYS 10.0421
GLU 20.0234
LEU 30.0409
ARG 40.0318
CYS 50.0235
GLN 60.0265
CYS 70.0090
ILE 80.0256
LYS 90.0230
THR 100.0127
TYR 110.0246
SER 120.0356
LYS 130.0355
PRO 140.0197
PHE 150.0169
HIS 160.0341
PRO 170.0195
LYS 180.0268
PHE 190.0232
ILE 200.0184
LYS 210.0216
GLU 220.0067
LEU 230.0091
ARG 240.0182
VAL 250.0260
ILE 260.0280
GLU 270.0275
SER 280.0130
GLY 290.0351
PRO 300.0239
HIS 310.0096
CYS 320.0059
ALA 330.0441
ASN 340.0058
THR 350.0058
GLU 360.0224
ILE 370.0175
ILE 380.0128
VAL 390.0103
LYS 400.0040
LEU 410.0096
SER 420.0155
ASP 430.0540
GLY 440.0140
ARG 450.0130
GLU 460.0070
LEU 470.0130
CYS 480.0088
LEU 490.0128
ASP 500.0146
PRO 510.0230
LYS 520.0869
GLU 530.0267
ASN 540.0113
TRP 550.0118
VAL 560.0109
GLN 570.0128
ARG 580.0084
VAL 590.0142
VAL 600.0123
GLU 610.0177
LYS 620.0135
PHE 630.0048
LEU 640.0134
LYS 650.0289
ARG 660.0223
ALA 670.0228
GLU 680.0212
ASN 690.0591

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.